
Enabling Biophysical Assays with Key Therapeutic Applications from AstraZeneca, Pfizer and Astex Pharmaceuticals
AstraZeneca,Pfizer,Astex Pharmaceuticals will discuss identification of lead inhibitors and structural optimisation of protein ligands with therapeutic efficacy LONDON, UNITED KINGDOM, November 13, 2015 /EINPresswire.com/ -- “Activity-based protein …